{"id":350457,"date":"2025-08-25T19:27:21","date_gmt":"2025-08-25T19:27:21","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-arvinas\/"},"modified":"2025-08-25T19:27:21","modified_gmt":"2025-08-25T19:27:21","slug":"how-to-buy-arvinas","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) v\u00e0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y v\u1edbi c\u00e1c y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y t\u1eeb FDA ph\u00eda tr\u01b0\u1edbc.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) v\u00e0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y v\u1edbi c\u00e1c y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y t\u1eeb FDA ph\u00eda tr\u01b0\u1edbc."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0? Arvinas \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. C\u00f4ng ty n\u00e0y \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu ARVN \u2014 t\u1eeb hi\u1ec7u su\u1ea5t hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c quy\u1ebft \u0111\u1ecbnh quan tr\u1ecdng c\u1ee7a FDA c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0? Arvinas \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. C\u00f4ng ty n\u00e0y \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu ARVN \u2014 t\u1eeb hi\u1ec7u su\u1ea5t hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c quy\u1ebft \u0111\u1ecbnh quan tr\u1ecdng c\u1ee7a FDA c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Arvinas: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Arvinas, Inc. (ARVN) giao d\u1ecbch \u1edf m\u1ee9c <strong>7,39 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>29 th\u00e1ng 10 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Arvinas c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ARVN<\/h3> <p>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 6 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 g\u00e2y ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3. C\u00f4ng ty b\u00e1o c\u00e1o doanh thu gi\u1ea3m 71% xu\u1ed1ng c\u00f2n 22,4 tri\u1ec7u USD do thu nh\u1eadp h\u1ee3p t\u00e1c gi\u1ea3m t\u1eeb Pfizer v\u00e0 k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng h\u1ed7n h\u1ee3p c\u1ee7a Vepdegestrant. \u0110i\u1ec1u n\u00e0y \u0111\u00e3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m g\u1ea7n 15% trong tu\u1ea7n ti\u1ebfp theo.<\/p> <p>Nh\u00ecn l\u1ea1i l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y:<\/p> <ul> <li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 4 g\u00e2y gi\u1ea3m 12% do c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m kh\u00f4ng nh\u01b0 mong \u0111\u1ee3i<\/li> <li><strong>Th\u00e1ng 11 n\u0103m 2024<\/strong>: Tin t\u1ee9c h\u1ee3p t\u00e1c v\u1edbi Genentech \u0111\u00e3 k\u00edch th\u00edch t\u0103ng 22%<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2024<\/strong>: K\u1ebft qu\u1ea3 qu\u00fd 2 cho th\u1ea5y ti\u1ebfn tri\u1ec3n nh\u01b0ng doanh thu kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh, d\u1eabn \u0111\u1ebfn gi\u1ea3m 8%<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2024<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 t\u00edch c\u1ef1c t\u1ea1o ra \u0111\u00e0 t\u0103ng 30% trong hai tu\u1ea7n<\/li> <\/ul> <p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: ARVN ph\u1ea3n \u1ee9ng m\u1ea1nh v\u1edbi k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 10 s\u1eafp t\u1edbi c\u00f3 th\u1ec3 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng do nh\u1eefng th\u00e1ch th\u1ee9c doanh thu g\u1ea7n \u0111\u00e2y.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 n\u0103m 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu Arvinas \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh \u0111\u1ea7y bi\u1ebfn \u0111\u1ed9ng trong s\u00e1u th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 9,80 USD (sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 4 g\u00e2y th\u1ea5t v\u1ecdng)<br\/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 11,20 USD (h\u1ed3i ph\u1ee5c nh\u1edd l\u1ea1c quan v\u1ec1 h\u1ee3p t\u00e1c)<br\/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 8,90 USD (bi\u1ebfn \u0111\u1ed9ng do b\u00e1n th\u00e1o trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc)<br\/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 10,50 USD (n\u00e2ng c\u1ea5p t\u00edch c\u1ef1c t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch)<br\/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 7,20 USD (gi\u1ea3m m\u1ea1nh do lo ng\u1ea1i doanh thu)<br\/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 6,80 USD (ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n)<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 7,39 USD (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p> <p>\u0110i\u1ec1u n\u00e0y th\u1ec3 hi\u1ec7n m\u1ee9c <strong>gi\u1ea3m 24,6%<\/strong> trong s\u00e1u th\u00e1ng, ch\u1ee7 y\u1ebfu do:<\/p> <ul> <li>B\u1ea5t \u0111\u1ecbnh trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <li>Thi\u1ebfu h\u1ee5t doanh thu t\u1eeb h\u1ee3p t\u00e1c v\u1edbi Pfizer<\/li> <li>S\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <\/ul> <p>Tuy nhi\u00ean, c\u1ed5 phi\u1ebfu \u0111\u00e3 cho th\u1ea5y s\u1ef1 ki\u00ean c\u01b0\u1eddng quanh m\u1ee9c h\u1ed7 tr\u1ee3 7 USD, g\u1ee3i \u00fd kh\u1ea3 n\u0103ng \u1ed5n \u0111\u1ecbnh.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn \u0111\u1ed9 ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 14-18 USD (gi\u1ea3 \u0111\u1ecbnh \u1ed5n \u0111\u1ecbnh v\u00e0 ph\u1ee5c h\u1ed3i nh\u1eb9) \u2192 <strong>MUA cho d\u00e0i h\u1ea1n<\/strong><\/li> <li><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 20-25 USD (quy\u1ebft \u0111\u1ecbnh FDA v\u1ec1 Vepdegestrant d\u1ef1 ki\u1ebfn th\u00e1ng 6 n\u0103m 2026)<\/li> <li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 35-45 USD (c\u00f3 th\u1ec3 th\u01b0\u01a1ng m\u1ea1i h\u00f3a v\u00e0 m\u1edf r\u1ed9ng h\u1ee3p t\u00e1c)<\/li> <li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 60-80+ USD (n\u1ebfu n\u1ec1n t\u1ea3ng ph\u00e2n h\u1ee7y protein th\u00e0nh c\u00f4ng tr\u00ean nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh)<\/li> <\/ul> <p>M\u1ee9c gi\u00e1 m\u1ee5c ti\u00eau trung b\u00ecnh c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch l\u00e0 <strong>20,21 USD<\/strong> theo d\u1eef li\u1ec7u g\u1ea7n \u0111\u00e2y t\u1eeb <a href=\"https:\/\/stockanalysis.com\/stocks\/arvn\/forecast\/\">StockAnalysis.com<\/a>, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng t\u0103ng 176% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p> <h3>T\u1ea1i Sao Tri\u1ec3n V\u1ecdng D\u00e0i H\u1ea1n L\u1ea1c Quan?<\/h3> <ol> <li><strong>Y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y FDA<\/strong>: Ng\u00e0y PDUFA 5 th\u00e1ng 6 n\u0103m 2026 cho Vepdegestrant<\/li> <li><strong>Ti\u1ec1m n\u0103ng n\u1ec1n t\u1ea3ng<\/strong>: C\u00f4ng ngh\u1ec7 PROTAC c\u00f3 th\u1ec3 nh\u1eafm \u0111\u1ebfn c\u00e1c m\u1ee5c ti\u00eau \"kh\u00f3 tr\u1ecb\"<\/li> <li><strong>H\u1ee3p t\u00e1c m\u1ea1nh m\u1ebd<\/strong>: H\u1ee3p t\u00e1c v\u1edbi Pfizer gi\u1ea3m r\u1ee7i ro ph\u00e1t tri\u1ec3n<\/li> <li><strong>D\u00f2ng ti\u1ec1n<\/strong>: Qu\u1ef9 \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn cu\u1ed1i n\u0103m 2028 theo b\u00e1o c\u00e1o m\u1edbi nh\u1ea5t<\/li> <\/ol> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% \u1ee9ng vi\u00ean thu\u1ed1c th\u1ea5t b\u1ea1i \u1edf giai \u0111o\u1ea1n cu\u1ed1i<\/li> <li><strong>Tr\u00ec ho\u00e3n quy \u0111\u1ecbnh<\/strong>: Quy\u1ebft \u0111\u1ecbnh FDA c\u00f3 th\u1ec3 b\u1ecb ho\u00e3n ho\u1eb7c y\u00eau c\u1ea7u th\u00eam d\u1eef li\u1ec7u<\/li> <li><strong>Ph\u1ee5 thu\u1ed9c doanh thu<\/strong>: Ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o thanh to\u00e1n h\u1ee3p t\u00e1c cho \u0111\u1ebfn khi th\u01b0\u01a1ng m\u1ea1i h\u00f3a<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: Beta 1,58 ngh\u0129a l\u00e0 bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n th\u1ecb tr\u01b0\u1eddng 58%<\/li> <li><strong>S\u1ef1 ki\u1ec7n nh\u1ecb ph\u00e2n<\/strong>: Gi\u00e1 c\u1ed5 phi\u1ebfu ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o v\u00e0i y\u1ebfu t\u1ed1 then ch\u1ed1t<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3> <ul> <li><strong>Ch\u1ea5p nh\u1eadn FDA<\/strong>: NDA Vepdegestrant \u0111\u01b0\u1ee3c ch\u1ea5p nh\u1eadn v\u1edbi ng\u00e0y quy\u1ebft \u0111\u1ecbnh th\u00e1ng 6 n\u0103m 2026<\/li> <li><strong>Th\u00e0nh c\u00f4ng Giai \u0111o\u1ea1n 3<\/strong>: Gi\u1ea3m 43% r\u1ee7i ro ti\u1ebfn tri\u1ec3n b\u1ec7nh trong th\u1eed nghi\u1ec7m<\/li> <li><strong>H\u1ed7 tr\u1ee3 t\u1ed5 ch\u1ee9c<\/strong>: XTX Topco t\u0103ng c\u1ed5 ph\u1ea7n 194% trong qu\u00fd 1 n\u0103m 2025<\/li> <li><strong>T\u1ef1 tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 12 \u0111\u00e1nh gi\u00e1 mua, 9 gi\u1eef, kh\u00f4ng c\u00f3 khuy\u1ebfn ngh\u1ecb b\u00e1n<\/li> <li><strong>X\u00e1c nh\u1eadn c\u00f4ng ngh\u1ec7<\/strong>: Thu\u1ed1c PROTAC \u0111\u1ea7u ti\u00ean s\u1eafp \u0111\u01b0\u1ee3c FDA xem x\u00e9t<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Mua t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i quanh c\u00e1c ng\u00e0y quan tr\u1ecdng nh\u01b0 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn 29 th\u00e1ng 10<\/li> <li><strong>C\u00f3 chi\u1ebfn l\u01b0\u1ee3c tho\u00e1t<\/strong>: Bi\u1ebft m\u1ee9c d\u1eebng l\u1ed7 tr\u01b0\u1edbc khi v\u00e0o l\u1ec7nh<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch ARVN gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc \u2014 \u0111\u1ea7y h\u1ed3i h\u1ed9p, th\u1ec9nh tho\u1ea3ng c\u00f3 \u0111\u1ed9t ph\u00e1, v\u00e0 b\u1ea1n s\u1ebd c\u1ea7n th\u1ea7n kinh th\u00e9p cho ph\u1ea7n k\u1ebft (quy\u1ebft \u0111\u1ecbnh FDA)!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td><td>Th\u01b0\u1eddng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"ARVN\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>6<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 t\u1ed5ng chi ph\u00ed<\/td><\/tr> <tr><td>7<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho tin t\u1ee9c v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li> <li><strong>X\u00e1c minh nhanh<\/strong> \u2014 th\u01b0\u1eddng d\u01b0\u1edbi 1 ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 ID ch\u00ednh ph\u1ee7 n\u00e0o<\/li> <li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n c\u00f3 s\u1eb5n<\/strong> \u2014 mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n kh\u00e1m ph\u00e1 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 ARVN m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 v\u1ed1n l\u1edbn ban \u0111\u1ea7u.<\/p> <h2>\ud83c\udf0d Arvinas N\u0103m 2025: Ti\u00ean Phong C\u00f4ng Ngh\u1ec7 Ph\u00e2n H\u1ee7y Protein<\/h2> <p>Arvinas \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau. N\u1ec1n t\u1ea3ng PROTAC c\u1ee7a c\u00f4ng ty \u0111\u1ea1i di\u1ec7n cho m\u1ed9t b\u01b0\u1edbc chuy\u1ec3n \u0111\u1ed5i ti\u1ec1m n\u0103ng trong \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1eb1ng c\u00e1ch t\u1eadn d\u1ee5ng h\u1ec7 th\u1ed1ng lo\u1ea1i b\u1ecf protein t\u1ef1 nhi\u00ean c\u1ee7a c\u01a1 th\u1ec3 thay v\u00ec c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u1ee9c ch\u1ebf truy\u1ec1n th\u1ed1ng.<\/p> <ul> <li><strong>Tr\u1ecdng t\u00e2m hi\u1ec7n t\u1ea1i<\/strong>: Ph\u00e1t tri\u1ec3n Vepdegestrant cho ung th\u01b0 v\u00fa v\u1edbi quy\u1ebft \u0111\u1ecbnh FDA d\u1ef1 ki\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li> <li><strong>S\u1ee9c m\u1ea1nh pipeline<\/strong>: Nhi\u1ec1u \u1ee9ng vi\u00ean trong th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 cho ung th\u01b0 tuy\u1ebfn ti\u1ec1n li\u1ec7t v\u00e0 c\u00e1c ch\u1ec9 \u0111\u1ecbnh kh\u00e1c<\/li> <li><strong>S\u1ee9c m\u1ea1nh h\u1ee3p t\u00e1c<\/strong>: H\u1ee3p t\u00e1c v\u1edbi Pfizer, Genentech v\u00e0 Bayer mang l\u1ea1i s\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh<\/li> <\/ul> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc Arvinas ph\u00e1t hi\u1ec7n r\u1eb1ng c\u00e1c ch\u1ea5t ph\u00e2n h\u1ee7y protein c\u1ee7a h\u1ecd c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf \u0111\u1ec3 \"k\u00edch ho\u1ea1t theo s\u1ef1 ki\u1ec7n\" thay v\u00ec \"d\u1ef1a tr\u00ean s\u1ef1 chi\u1ebfm gi\u1eef\", ngh\u0129a l\u00e0 ch\u00fang ch\u1ec9 ho\u1ea1t \u0111\u1ed9ng khi c\u1ea7n v\u00e0 sau \u0111\u00f3 t\u1ef1 \u0111\u1ed9ng ng\u1eaft k\u1ebft n\u1ed1i \u2014 m\u1ed9t \u0111\u1ed9t ph\u00e1 c\u00f3 th\u1ec3 gi\u1ea3m \u0111\u00e1ng k\u1ec3 t\u00e1c d\u1ee5ng ph\u1ee5.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Arvinas: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Arvinas, Inc. (ARVN) giao d\u1ecbch \u1edf m\u1ee9c <strong>7,39 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>29 th\u00e1ng 10 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Arvinas c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ARVN<\/h3>\n<p>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 6 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 g\u00e2y ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3. C\u00f4ng ty b\u00e1o c\u00e1o doanh thu gi\u1ea3m 71% xu\u1ed1ng c\u00f2n 22,4 tri\u1ec7u USD do thu nh\u1eadp h\u1ee3p t\u00e1c gi\u1ea3m t\u1eeb Pfizer v\u00e0 k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng h\u1ed7n h\u1ee3p c\u1ee7a Vepdegestrant. \u0110i\u1ec1u n\u00e0y \u0111\u00e3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m g\u1ea7n 15% trong tu\u1ea7n ti\u1ebfp theo.<\/p>\n<p>Nh\u00ecn l\u1ea1i l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 4 g\u00e2y gi\u1ea3m 12% do c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m kh\u00f4ng nh\u01b0 mong \u0111\u1ee3i<\/li>\n<li><strong>Th\u00e1ng 11 n\u0103m 2024<\/strong>: Tin t\u1ee9c h\u1ee3p t\u00e1c v\u1edbi Genentech \u0111\u00e3 k\u00edch th\u00edch t\u0103ng 22%<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2024<\/strong>: K\u1ebft qu\u1ea3 qu\u00fd 2 cho th\u1ea5y ti\u1ebfn tri\u1ec3n nh\u01b0ng doanh thu kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh, d\u1eabn \u0111\u1ebfn gi\u1ea3m 8%<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2024<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 t\u00edch c\u1ef1c t\u1ea1o ra \u0111\u00e0 t\u0103ng 30% trong hai tu\u1ea7n<\/li>\n<\/ul>\n<p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: ARVN ph\u1ea3n \u1ee9ng m\u1ea1nh v\u1edbi k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 10 s\u1eafp t\u1edbi c\u00f3 th\u1ec3 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng do nh\u1eefng th\u00e1ch th\u1ee9c doanh thu g\u1ea7n \u0111\u00e2y.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 n\u0103m 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu Arvinas \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh \u0111\u1ea7y bi\u1ebfn \u0111\u1ed9ng trong s\u00e1u th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 9,80 USD (sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 4 g\u00e2y th\u1ea5t v\u1ecdng)<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 11,20 USD (h\u1ed3i ph\u1ee5c nh\u1edd l\u1ea1c quan v\u1ec1 h\u1ee3p t\u00e1c)<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 8,90 USD (bi\u1ebfn \u0111\u1ed9ng do b\u00e1n th\u00e1o trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc)<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 10,50 USD (n\u00e2ng c\u1ea5p t\u00edch c\u1ef1c t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch)<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 7,20 USD (gi\u1ea3m m\u1ea1nh do lo ng\u1ea1i doanh thu)<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 6,80 USD (ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n)<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 7,39 USD (\u1ed5n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i)<\/p>\n<p>\u0110i\u1ec1u n\u00e0y th\u1ec3 hi\u1ec7n m\u1ee9c <strong>gi\u1ea3m 24,6%<\/strong> trong s\u00e1u th\u00e1ng, ch\u1ee7 y\u1ebfu do:<\/p>\n<ul>\n<li>B\u1ea5t \u0111\u1ecbnh trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<li>Thi\u1ebfu h\u1ee5t doanh thu t\u1eeb h\u1ee3p t\u00e1c v\u1edbi Pfizer<\/li>\n<li>S\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<\/ul>\n<p>Tuy nhi\u00ean, c\u1ed5 phi\u1ebfu \u0111\u00e3 cho th\u1ea5y s\u1ef1 ki\u00ean c\u01b0\u1eddng quanh m\u1ee9c h\u1ed7 tr\u1ee3 7 USD, g\u1ee3i \u00fd kh\u1ea3 n\u0103ng \u1ed5n \u0111\u1ecbnh.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn \u0111\u1ed9 ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 14-18 USD (gi\u1ea3 \u0111\u1ecbnh \u1ed5n \u0111\u1ecbnh v\u00e0 ph\u1ee5c h\u1ed3i nh\u1eb9) \u2192 <strong>MUA cho d\u00e0i h\u1ea1n<\/strong><\/li>\n<li><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 20-25 USD (quy\u1ebft \u0111\u1ecbnh FDA v\u1ec1 Vepdegestrant d\u1ef1 ki\u1ebfn th\u00e1ng 6 n\u0103m 2026)<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 35-45 USD (c\u00f3 th\u1ec3 th\u01b0\u01a1ng m\u1ea1i h\u00f3a v\u00e0 m\u1edf r\u1ed9ng h\u1ee3p t\u00e1c)<\/li>\n<li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 60-80+ USD (n\u1ebfu n\u1ec1n t\u1ea3ng ph\u00e2n h\u1ee7y protein th\u00e0nh c\u00f4ng tr\u00ean nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh)<\/li>\n<\/ul>\n<p>M\u1ee9c gi\u00e1 m\u1ee5c ti\u00eau trung b\u00ecnh c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch l\u00e0 <strong>20,21 USD<\/strong> theo d\u1eef li\u1ec7u g\u1ea7n \u0111\u00e2y t\u1eeb <a href=\"https:\/\/stockanalysis.com\/stocks\/arvn\/forecast\/\">StockAnalysis.com<\/a>, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng t\u0103ng 176% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p>\n<h3>T\u1ea1i Sao Tri\u1ec3n V\u1ecdng D\u00e0i H\u1ea1n L\u1ea1c Quan?<\/h3>\n<ol>\n<li><strong>Y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y FDA<\/strong>: Ng\u00e0y PDUFA 5 th\u00e1ng 6 n\u0103m 2026 cho Vepdegestrant<\/li>\n<li><strong>Ti\u1ec1m n\u0103ng n\u1ec1n t\u1ea3ng<\/strong>: C\u00f4ng ngh\u1ec7 PROTAC c\u00f3 th\u1ec3 nh\u1eafm \u0111\u1ebfn c\u00e1c m\u1ee5c ti\u00eau &#8220;kh\u00f3 tr\u1ecb&#8221;<\/li>\n<li><strong>H\u1ee3p t\u00e1c m\u1ea1nh m\u1ebd<\/strong>: H\u1ee3p t\u00e1c v\u1edbi Pfizer gi\u1ea3m r\u1ee7i ro ph\u00e1t tri\u1ec3n<\/li>\n<li><strong>D\u00f2ng ti\u1ec1n<\/strong>: Qu\u1ef9 \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn cu\u1ed1i n\u0103m 2028 theo b\u00e1o c\u00e1o m\u1edbi nh\u1ea5t<\/li>\n<\/ol>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% \u1ee9ng vi\u00ean thu\u1ed1c th\u1ea5t b\u1ea1i \u1edf giai \u0111o\u1ea1n cu\u1ed1i<\/li>\n<li><strong>Tr\u00ec ho\u00e3n quy \u0111\u1ecbnh<\/strong>: Quy\u1ebft \u0111\u1ecbnh FDA c\u00f3 th\u1ec3 b\u1ecb ho\u00e3n ho\u1eb7c y\u00eau c\u1ea7u th\u00eam d\u1eef li\u1ec7u<\/li>\n<li><strong>Ph\u1ee5 thu\u1ed9c doanh thu<\/strong>: Ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o thanh to\u00e1n h\u1ee3p t\u00e1c cho \u0111\u1ebfn khi th\u01b0\u01a1ng m\u1ea1i h\u00f3a<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: Beta 1,58 ngh\u0129a l\u00e0 bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n th\u1ecb tr\u01b0\u1eddng 58%<\/li>\n<li><strong>S\u1ef1 ki\u1ec7n nh\u1ecb ph\u00e2n<\/strong>: Gi\u00e1 c\u1ed5 phi\u1ebfu ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o v\u00e0i y\u1ebfu t\u1ed1 then ch\u1ed1t<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3>\n<ul>\n<li><strong>Ch\u1ea5p nh\u1eadn FDA<\/strong>: NDA Vepdegestrant \u0111\u01b0\u1ee3c ch\u1ea5p nh\u1eadn v\u1edbi ng\u00e0y quy\u1ebft \u0111\u1ecbnh th\u00e1ng 6 n\u0103m 2026<\/li>\n<li><strong>Th\u00e0nh c\u00f4ng Giai \u0111o\u1ea1n 3<\/strong>: Gi\u1ea3m 43% r\u1ee7i ro ti\u1ebfn tri\u1ec3n b\u1ec7nh trong th\u1eed nghi\u1ec7m<\/li>\n<li><strong>H\u1ed7 tr\u1ee3 t\u1ed5 ch\u1ee9c<\/strong>: XTX Topco t\u0103ng c\u1ed5 ph\u1ea7n 194% trong qu\u00fd 1 n\u0103m 2025<\/li>\n<li><strong>T\u1ef1 tin c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 12 \u0111\u00e1nh gi\u00e1 mua, 9 gi\u1eef, kh\u00f4ng c\u00f3 khuy\u1ebfn ngh\u1ecb b\u00e1n<\/li>\n<li><strong>X\u00e1c nh\u1eadn c\u00f4ng ngh\u1ec7<\/strong>: Thu\u1ed1c PROTAC \u0111\u1ea7u ti\u00ean s\u1eafp \u0111\u01b0\u1ee3c FDA xem x\u00e9t<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Mua t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i quanh c\u00e1c ng\u00e0y quan tr\u1ecdng nh\u01b0 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn 29 th\u00e1ng 10<\/li>\n<li><strong>C\u00f3 chi\u1ebfn l\u01b0\u1ee3c tho\u00e1t<\/strong>: Bi\u1ebft m\u1ee9c d\u1eebng l\u1ed7 tr\u01b0\u1edbc khi v\u00e0o l\u1ec7nh<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch ARVN gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc \u2014 \u0111\u1ea7y h\u1ed3i h\u1ed9p, th\u1ec9nh tho\u1ea3ng c\u00f3 \u0111\u1ed9t ph\u00e1, v\u00e0 b\u1ea1n s\u1ebd c\u1ea7n th\u1ea7n kinh th\u00e9p cho ph\u1ea7n k\u1ebft (quy\u1ebft \u0111\u1ecbnh FDA)!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>Th\u01b0\u1eddng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;ARVN&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 t\u1ed5ng chi ph\u00ed<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho tin t\u1ee9c v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li>\n<li><strong>X\u00e1c minh nhanh<\/strong> \u2014 th\u01b0\u1eddng d\u01b0\u1edbi 1 ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 ID ch\u00ednh ph\u1ee7 n\u00e0o<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n c\u00f3 s\u1eb5n<\/strong> \u2014 mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n kh\u00e1m ph\u00e1 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 ARVN m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 v\u1ed1n l\u1edbn ban \u0111\u1ea7u.<\/p>\n<h2>\ud83c\udf0d Arvinas N\u0103m 2025: Ti\u00ean Phong C\u00f4ng Ngh\u1ec7 Ph\u00e2n H\u1ee7y Protein<\/h2>\n<p>Arvinas \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau. N\u1ec1n t\u1ea3ng PROTAC c\u1ee7a c\u00f4ng ty \u0111\u1ea1i di\u1ec7n cho m\u1ed9t b\u01b0\u1edbc chuy\u1ec3n \u0111\u1ed5i ti\u1ec1m n\u0103ng trong \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1eb1ng c\u00e1ch t\u1eadn d\u1ee5ng h\u1ec7 th\u1ed1ng lo\u1ea1i b\u1ecf protein t\u1ef1 nhi\u00ean c\u1ee7a c\u01a1 th\u1ec3 thay v\u00ec c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u1ee9c ch\u1ebf truy\u1ec1n th\u1ed1ng.<\/p>\n<ul>\n<li><strong>Tr\u1ecdng t\u00e2m hi\u1ec7n t\u1ea1i<\/strong>: Ph\u00e1t tri\u1ec3n Vepdegestrant cho ung th\u01b0 v\u00fa v\u1edbi quy\u1ebft \u0111\u1ecbnh FDA d\u1ef1 ki\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li>\n<li><strong>S\u1ee9c m\u1ea1nh pipeline<\/strong>: Nhi\u1ec1u \u1ee9ng vi\u00ean trong th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 cho ung th\u01b0 tuy\u1ebfn ti\u1ec1n li\u1ec7t v\u00e0 c\u00e1c ch\u1ec9 \u0111\u1ecbnh kh\u00e1c<\/li>\n<li><strong>S\u1ee9c m\u1ea1nh h\u1ee3p t\u00e1c<\/strong>: H\u1ee3p t\u00e1c v\u1edbi Pfizer, Genentech v\u00e0 Bayer mang l\u1ea1i s\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh<\/li>\n<\/ul>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc Arvinas ph\u00e1t hi\u1ec7n r\u1eb1ng c\u00e1c ch\u1ea5t ph\u00e2n h\u1ee7y protein c\u1ee7a h\u1ecd c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf \u0111\u1ec3 &#8220;k\u00edch ho\u1ea1t theo s\u1ef1 ki\u1ec7n&#8221; thay v\u00ec &#8220;d\u1ef1a tr\u00ean s\u1ef1 chi\u1ebfm gi\u1eef&#8221;, ngh\u0129a l\u00e0 ch\u00fang ch\u1ec9 ho\u1ea1t \u0111\u1ed9ng khi c\u1ea7n v\u00e0 sau \u0111\u00f3 t\u1ef1 \u0111\u1ed9ng ng\u1eaft k\u1ebft n\u1ed1i \u2014 m\u1ed9t \u0111\u1ed9t ph\u00e1 c\u00f3 th\u1ec3 gi\u1ea3m \u0111\u00e1ng k\u1ec3 t\u00e1c d\u1ee5ng ph\u1ee5.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu ARVN, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"Arvinas c\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o khi \u0111\u1ea7u t\u01b0?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, tr\u00ec ho\u00e3n quy \u0111\u1ecbnh t\u1eeb FDA, ph\u1ee5 thu\u1ed9c doanh thu t\u1eeb h\u1ee3p t\u00e1c, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 s\u1ef1 ph\u1ee5 thu\u1ed9c v\u00e0o m\u1ed9t s\u1ed1 s\u1ef1 ki\u1ec7n then ch\u1ed1t."},{"question":"Tri\u1ec3n v\u1ecdng gi\u00e1 c\u1ed5 phi\u1ebfu Arvinas trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 \u0111\u1ea1t t\u1eeb 60 \u0111\u1ebfn 80 USD ho\u1eb7c h\u01a1n n\u1ebfu n\u1ec1n t\u1ea3ng ph\u00e2n h\u1ee7y protein th\u00e0nh c\u00f4ng tr\u00ean nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh, v\u1edbi m\u1ee9c gi\u00e1 m\u1ee5c ti\u00eau trung b\u00ecnh hi\u1ec7n t\u1ea1i kho\u1ea3ng 20,21 USD."},{"question":"T\u1ea1i sao c\u00f4ng ngh\u1ec7 PROTAC c\u1ee7a Arvinas l\u1ea1i quan tr\u1ecdng?","answer":"C\u00f4ng ngh\u1ec7 PROTAC c\u00f3 th\u1ec3 nh\u1eafm \u0111\u1ebfn c\u00e1c m\u1ee5c ti\u00eau \"kh\u00f3 tr\u1ecb\" b\u1eb1ng c\u00e1ch t\u1eadn d\u1ee5ng h\u1ec7 th\u1ed1ng lo\u1ea1i b\u1ecf protein t\u1ef1 nhi\u00ean c\u1ee7a c\u01a1 th\u1ec3, m\u1edf ra c\u00e1ch ti\u1ebfp c\u1eadn m\u1edbi trong \u0111i\u1ec1u tr\u1ecb b\u1ec7nh."},{"question":"Nh\u1eefng l\u1ee3i th\u1ebf khi s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 ARVN l\u00e0 g\u00ec?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, x\u00e1c minh nhanh, mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n, v\u00e0 c\u00f3 h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu ARVN, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"Arvinas c\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o khi \u0111\u1ea7u t\u01b0?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, tr\u00ec ho\u00e3n quy \u0111\u1ecbnh t\u1eeb FDA, ph\u1ee5 thu\u1ed9c doanh thu t\u1eeb h\u1ee3p t\u00e1c, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 s\u1ef1 ph\u1ee5 thu\u1ed9c v\u00e0o m\u1ed9t s\u1ed1 s\u1ef1 ki\u1ec7n then ch\u1ed1t."},{"question":"Tri\u1ec3n v\u1ecdng gi\u00e1 c\u1ed5 phi\u1ebfu Arvinas trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 \u0111\u1ea1t t\u1eeb 60 \u0111\u1ebfn 80 USD ho\u1eb7c h\u01a1n n\u1ebfu n\u1ec1n t\u1ea3ng ph\u00e2n h\u1ee7y protein th\u00e0nh c\u00f4ng tr\u00ean nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh, v\u1edbi m\u1ee9c gi\u00e1 m\u1ee5c ti\u00eau trung b\u00ecnh hi\u1ec7n t\u1ea1i kho\u1ea3ng 20,21 USD."},{"question":"T\u1ea1i sao c\u00f4ng ngh\u1ec7 PROTAC c\u1ee7a Arvinas l\u1ea1i quan tr\u1ecdng?","answer":"C\u00f4ng ngh\u1ec7 PROTAC c\u00f3 th\u1ec3 nh\u1eafm \u0111\u1ebfn c\u00e1c m\u1ee5c ti\u00eau \"kh\u00f3 tr\u1ecb\" b\u1eb1ng c\u00e1ch t\u1eadn d\u1ee5ng h\u1ec7 th\u1ed1ng lo\u1ea1i b\u1ecf protein t\u1ef1 nhi\u00ean c\u1ee7a c\u01a1 th\u1ec3, m\u1edf ra c\u00e1ch ti\u1ebfp c\u1eadn m\u1edbi trong \u0111i\u1ec1u tr\u1ecb b\u1ec7nh."},{"question":"Nh\u1eefng l\u1ee3i th\u1ebf khi s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 ARVN l\u00e0 g\u00ec?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, x\u00e1c minh nhanh, mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n, v\u00e0 c\u00f3 h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:27:21+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)\",\"datePublished\":\"2025-08-25T19:27:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T19:27:21+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:27:21+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)","datePublished":"2025-08-25T19:27:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T19:27:21+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-arvinas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Arvinas, Inc. (ARVN)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":350459,"slug":"how-to-buy-arvinas","post_title":"Como comprar a\u00e7\u00f5es da Arvinas, Inc. (ARVN) - Investimento em a\u00e7\u00f5es da Arvinas, Inc. (ARVN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-arvinas\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=350457"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=350457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=350457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=350457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}